U.S. firm Storable to ramp up hiring for Hyderabad facility
March 27, 2024
Dive into China’s growing streaming industry
March 18, 2024
Writer-turned-lawmaker’s pursuit for better rural China
March 26, 2024
Image for representation onlyNEW DELHI: India is all set to launch on Thursday its first indigenously developed quadrivalent Human Papilloma ...
Cervavac, India’s first vaccine to fight cervical cancer, has received a nod from the DCGI. To be launched later in ...
The Drugs Controller General of India has recommended allowing Serum Institute of India to manufacture and stockpile their life-saving qHPV ...
The government advisory panel NTAGI is likely to review on June 28 trial data on India's first quadrivalent human papillomavirus ...
New Delhi: The Drugs Controller General of India's (DCGI) Subject Expert Committee on Wednesday recommended Serum Institute's indigenously developed quadrivalent ...
New Delhi, Serum Institute of India (SII) has applied to the country's drug regulator seeking market authorisation to manufacture indigenously ...
The Serum Institute of India (SII) has sought the government's permission to manufacture and stockpile indigenously developed Quadrivalent Human Papillomavirus ...
The Serum Institute of India has sought the government's permission to manufacture and stockpile indigenously developed Quadrivalent Human Papillomavirus (qHPV) ...
Copyright © 2021 Asia Post.
Asia Post is not responsible for the content of external sites.